Primary record
2-[4-[(5,6-Diphenyl-2-pyrazinyl)(1-methylethyl)amino]butoxy]-N-(methylsulfonyl)acetamide; 2-[4-[(5,6-Diphenylpyrazin-2-yl)(isopropyl)amino]butoxy]-N-(methylsulfonyl)acetamide; ACT 293987; NS 304; Uptravi;
- 库存
- 3,785 克
- 纯度
- 98.5 %
- CAS
- 475086-01-2
化合物标识与属性
- CAS
- 475086-01-2
- PubChem CID
- 9913767
- SMILES
- CC(C)N(CCCCOCC(=O)NS(=O)(=O)C)C1=CN=C(C(=N1)C2=CC=CC=C2)C3=CC=CC=C3
- Canonical SMILES
- CC(C)N(CCCCOCC(=O)NS(C)(=O)=O)c1cnc(-c2ccccc2)c(-c2ccccc2)n1
名称与同义词
- Selexipag
- Uptravi
- NS-304
- 475086-01-2
- selexipagum
- ACT-293987
- Uptravi (TN)
- NS 304
- Selexipag (Standard)
- Selexipag [USAN:INN]
- Uptravi Titration Pack
- NS-304(Selexipag)
- Selexipag(NS-304)
- RefChem:58598
- SELEXIPAG [INN]
- SELEXIPAG [JAN]
- SELEXIPAG [MI]
- SELEXIPAG [USAN]
- NS-304(Selexipag)?
- 5EXC0E384L
- UNII-5EXC0E384L
- D0N2SR
- SELEXIPAG [WHO-DD]
- Selexipag TITRATION PACK
- ACT 293987
- C26H32N4O4S
- CHEBI:90844
- Selexipag (JAN/USAN/INN)
- SCHEMBL674122
- ACT293987
- MFCD10567093
- CHEMBL238804
- DTXSID301027959
- GTPL7552
- orb1304415
- SELEXIPAG [ORANGE BOOK]
- SCHEMBL29360518
- CTK8F0123
- B01AC27
- QXWZQTURMXZVHJ-UHFFFAOYSA-N
- DTXCID501513526
- GLXC-27569
- HMS5082O03
- AMY10851
- BCP09146
- EX-A7991
- ZINC3990451
- 3938AH
- BDBM50235383
- EBC-13811
- HY-14870R
- s3726
- NS-304;ACT-293987
- 2-(4-((5,6-diphenylpyrazin-2-yl)(isopropyl)amino)butoxy)-N-(methylsulfonyl)acetamide
- AKOS024457572
- CCG-269668
- CID9913767
- CS-3774
- DB11362
- SB17055
- KS-00000L89
- NCGC00370833-01
- NCGC00370833-02
- AC-30209
- AK298890
- BS-16872
- FD106425
- HY-14870
- SY236548
- DB-119997
- RT-014761
- B7378
- FT-0776043
- NS00069732
- J2.120.977E
- A13880
- D09994
- EN300-7378417
- 144383-EP2289518A1
- 144383-EP2292231A1
- A857156
- 2-[4-[(5,6-Diphenyl-2-pyrazinyl)(1-methylethyl)amino]butoxy]-N-(methylsulfonyl)acetamide
- 2-[4-[(5,6-diphenylpyrazin-2-yl)-propan-2-ylamino]butoxy]-N-methylsulfonylacetamide
- 2-{4-[(5,6-diphenylpyrazin-2-yl)(propan-2-yl)amino]butoxy}-N-(methanesulfonyl)acetamide
- BRD-K21191422-001-01-5
- Q15424759
- 2-{4-[(5,6-diphenylpyrazin-2-yl)(propan-2-yl)amino]butoxy}-N-methanesulfonylacetamide
- B2693-313936
- 2-(4-((5,6-Diphenylpyrazin-2-yl)(propan-2-yl)amino)butoxy}-n-(methanesulfonyl)acetamide
- 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}-N-(methylsulfonyl)acetamide
- 2-(4-((5,6-di(phenyl)pyrazin-2-yl)-propan-2-ylamino)butoxy)-N-methylsulfonylacetamide
- 2-(4-((5,6-Diphenyl-2-pyrazinyl)(1-methylethyl)amino)butoxy)-N-(methylsulfonyl)acetamide
- 2-(4-((5,6-diphenyl-2-pyrazinyl)(isopropyl)amino)butoxy)-n-(methylsulfonyl)acetamide
- 2-(4-((5,6-diphenylpyrazin-2-yl)(propan-2-yl)amino)butoxy)-N-methanesulfonylacetamide
- 2-(4-((5,6-Diphenylpyrazinyl)(1-methylethyl)amino)butoxy)-N-(methylsulfonyl)-acetamide
- 2-[4-[(5,6-Diphenyl-2-pyrazinyl)(isopropyl)amino]butoxy]-N-(methylsulfonyl)acetamide
- 2-[4-[(5,6-diphenylpyrazin-2-yl)-isopropyl-amino]butoxy]-N-methylsulfonyl-acetamide
- 2-[4-[(5,6-diphenylpyrazin-2-yl)-propan-2-yl-amino]butoxy]-N-methylsulfonyl-acetamide
- 2-[4-[[5,6-di(phenyl)pyrazin-2-yl]-propan-2-ylamino]butoxy]-N-methylsulfonylacetamide
- N-(Methylsulfonyl)-2-[4-[isopropyl(5,6-diphenylpyrazine-2-yl)amino]butoxy]acetamide
- N-(Methylsulfonyl)-2-[4-[isopropyl(5,6-diphenylpyrazine-2-yl)amino]butyloxy]acetamide
- 2-(4-((5,6-DIPHENYLPYRAZIN-2-YL)(PROPAN-2-YL)AMINO)BUTOXY)-N-(METHANESULFONYL)ACETAMIDE
- 2-[4-[(5,6-Diphenyl-2-pyrazinyl)(1-methylethyl)amino]butoxy]-N-(methylsulfonyl)acetamide; 2-[4-[(5,6-Diphenylpyrazin-2-yl)(isopropyl)amino]butoxy]-N-(methylsulfonyl)acetamide; ACT 293987; NS 304; Uptravi;